|
|
|
|
|
|
|
|
|
|
|
|
What's new ?
|
Tuesday, 12 August 2008 |
|
We are very appreciate to inform you that OPTOPOL Technology bought 70% of share in Medi.com Company. We invite you to visit web-site of Medi.com www.medi.com.pl |
|
Wednesday, 30 April 2008 |
OPTOPOL Technology S.A. is looking for: CRM – Clinical Research Manager
Duties:
1. Lead the clinical advisory board
2. Lead research and clinical initiatives around the world
3. Advise on product development
4. Support and enhance objectives of clinical advisory board
Requirements:
1. Medical background – ophthalmology preferred
2. Fluent English
3. Traveling required
For more details, please contact Dr. Dheeraj Bansal:
e-mail: d.bansal@optopol.com.pl
mobile: +48 604 89 33 57
|
|
Tuesday, 01 April 2008 |
|
Source: Med- info , str.15 , 01.04.2008r.
Article in original version
Firma Optopol Technology z Zawiercia kupiła udziały w kapitale zakładowym słoweńskiej firmy Optotek d.o.o. Firma nabyła akcje o łącznej wartości 5 218 844,98 euro i tym samym będzie dysponować 73,83 proc. kapitału zakładowego Optoteku. Jak poinformować zarząd Optopolu, umowa jest realizacją strategii spółki, która chce poszerzyć ofertę produkowanych i sprzedawanych przez firmę urządzeń medycznych przez przejęcie podmiotów z branży medycznej. Optopol Technology S.A. jest częścią Grupy Optopol. Firma zajmuje się projektowaniem, wytwarzaniem i sprzedażą specjalistycznego sprzętu medycznego dla diagnostyki okulistycznej. |
|
Wednesday, 05 March 2008 |
Optopol Technology S.A. the producer of most innovative technologies used for manufacturing modern diagnostics equipment in ophtalmology has received the FDA - Food and Drug Administration Certificate for Spectral Optical Tomography SOCT Copernicus.
Gaining this certificate lets our company introduce SOCT Copernicus to the market in the USA. The exclusive distributor of Optopol Technology S.A. devices on American market is Reichert Company. |
|
Tuesday, 05 February 2008 |
|
Emission of Serie E Shares is intended to gain Money to finance the investment programme started In 2007 as well as for planned investment. The Company forecasts that gross receipts from emission of E Series Shares will be about 80 mln PLN, and the net income (after deducting the emission costs) will be about 78 mln PLN. The Company will cover the remaining amount of money indispensable to realize the planned actions and investments from its own money or loans and planned grants from European Union programmes (among others agreement signed in June 2007 with Polish Agency for Enterprise Development in programme 2.2.1. Sector Operating Programme Improvement of the Competitiveness of Enterprises, or other supportive sources available for companies (e.g. Minister of Science and Higher Education enterprise “Technological Initiative”) and also extinguishing the credit of Technological Loan granted to Company.
The money gained by the Company will be spent from 2008 to 2009 to realize the aims.
Plans for spending money.
Expansion and development of offer which includes products made by the Company by conducting research and development works on new devices for ophthalmologists and optometrists – app. 10 mln PLN
|
|
Read more...
|
|
Tuesday, 05 February 2008 |
To 5 February 2008 – Maximum Price released to public;
6 – 7 February 2008 to 3.00p.m. – building Book of Demand – among Institutional Investors;
7 February 2008 – Fixing and releasing to public the Emission Price and final number of Offered Shares and the distribution for portions in Open Offer;
8 – 11 February 2008 – Subscription for Offered Shares in Closed Offer;
8 – 12 February – Subscription for Offered Shares in Retail Investors Portions and in Institutional Investors’ Portion;
12 February 2008 – Closing the subscription;
In 3 work-days from closing day of subscription – allocation of Offered Shares in Retail Investors’ Portions on Stock – exchange session;
In 3 work-days from closing day of subscription – allocation of Institutional Investors’ Portions in Closed Portion;
February 2008 – Stock – Exchange debut; |
|
Monday, 04 February 2008 |
Yesterday Polish Financial Supervision Authority approved IPO Prospectus of Optopol Technology S.A., the producer of the most modern technologies used to manufacture ophthalmic diagnostic devices in the world market.
The company is going to gain several millions of PLN for further development e.g. to continue research and development activities on new devices, to widen the offer for sale by taking over medical branch companies, as well as development of sales network in key markets. The public offer is planned in the first half of 2008. |
|
Read more...
|
|
Wednesday, 30 January 2008 |
New software version 2.0 for SOCT Copernicus - ask your distributor |
|
Wednesday, 05 December 2007 |
Source: manager magazin 12/07
Author: Piotr Stefaniak
Article in original version
Innowacje. Wielu polskich menedżerów nie rozumie sensu stawiania na innowacyjność. Zdecydowanie za małe nakłady na badania i rozwój oraz zły model współpracy polskiej nauki z naszymi przedsiębiorstwami nie biorą się więc z niczego.
Człowiek z natury jest leniwy i dlatego wymyśla kolejne wynalazki. Większość pomysłów rodzi się w czasie pokoju, z chęci ulżenia sobie w pracy, podniesienia jej wydajności lub w celach... rozrywkowych. Powstają planowo, metodycznie albo przypadkowo - jak stało się z jednym z najnowszych wynalazków, który za jakiś czas może doprowadzić do przełomu w technice i przemyśle.
Ideę bezprzewodowego przekazu energii, opartego na zjawisku rezonansu dwóch cewek, stworzył prof. Marin Soljacic (rocznik 1974) ponoć wtedy, gdy kolejny raz obudził go w nocy telefon komórkowy przypominający, że musi go doładować. Rozwijał ją z zespołem badawczym z prestiżowej amerykańskiej uczelni MIT, aż w czerwcu tego roku zapalił sześćdziesięciowatową żarówkę, która nie była podłączona kablem do źródła energii. Czy Polacy są zatem mniej leniwi, że tak mało słychać o ich wynalazkach?
|
|
Read more...
|
|
Tuesday, 04 December 2007 |
On 10th - 13th of November 2007 OPTOPOL Technology was participating in American Academy of Ophthalmology in New Orleans.
We were presenting new products:
- SOCT Copernicus HR
- SOCT Anterius
- PTS 1000
- PCT 200
Please, visit our galery »
|
|
|
|
|
|
|
|
|
|
|
(c) OPTOPOL Technology S.A. All rights reserved.
|
created by INTERSUM
|
